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In several model systems (1)  used to examine persistent  viral infections, cells are 
clearly infected,  yet  they may produce only little  amounts  of infectious virus.  One 
explanation  for  this  phenomenon  was  furnished  by  Scheid  and  Choppin  (2)  and 
Homma and Ohuchi  (3), whose experiments provided evidence that the infected host 
tissue  or cell  lacked an  appropriate  function  for virus maturation,  resulting  in  the 
failure to produce  infectious  virions.  From  their studies  using Sendai  virus, investi- 
gators concluded  (4-7) that proteolytic cleavage of one particular virus glycoprotein, 
the fusion protein, was required for infectivity, biologic function and pathogenicity. 
Measles  virus,  a  paramyxovirus  that  infects  humans,  is  structurally  similar  to 
Sendai virus in that measles virus expresses two surface glycoproteins, hemagglutinin 
(HA) 1 and fusion  (F)  protein, and shares other common structural  features  (8).  For 
measles  virus  infection,  these  two  polypeptides  are  important  in  related  disease. 
Typically,  in  acute  infection  of humans,  the  HA and  F  proteins  of measles  virus 
appear on the surfaces of infected cells where they act as immunogens, as recognition 
sites for antibody, complement, and/or immune lymphocytes (reviewed in 9 and  10). 
However, unlike  acute  infection  in persistent  measles virus infection,  subacute scle- 
rosing panencephalitis, both HA and F are usually absent from the cell's surface (11, 
12).  In such persistent infection, measles virus genome is found in cells of the central 
nervous system and/or lymphoid tissues. Virus may be recovered from these ceils after 
extensive cocultivation with feeder cells capable of replicating measles virus (13-17). 
This suggests  that  although  brain  or lymphoid  cells become infected with  measles 
virus, they lack some function or are defective in such a  way that a productive virus 
infection does not usually occur (6). 
To better understand  the pathobiology of measles virus infection, we have studied 
measles virus-lymphoid cell interactions.  Lymphoid cells were selected because these 
cells can harbor viruses during natural acute and persistent infection (17-19). Further 
aberrant  immune responses occur during  measles virus infection  (20,  reviewed  21). 
We evaluate how the  surface glycoproteins HA and  F  of measles virus function  in 
human  lymphoid cells during  virus infection.  To answer this question,  we infected 
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several lymphoid cell lines with measles virus and compared their susceptibilities to 
infection and  expression  of cell  surface  viral  glycoproteins.  We  found  that  some 
lymphoblasts do not cleave the F protein and produce only small amounts of infectious 
virus. The defect in F cleavage can be reconstituted by fusing these infected lympho- 
blasts  with  uninfected cells  possessing  the  appropriate  cleaving enzyme(s)  or  by 
treatment with a  proteolytic enzyme like trypsin. 
Materials and Methods 
Virus.  The Edmonston strain of measles virus was plaque purified twice on Veto cells and 
passed at  a  low  multiplicity of infection (MOI)--0.05 plaque-forming units (PFU)/cell--in 
HeLa cells, after which a stock virus pool was made in Vero cells. The passage history of this 
virus has been reported (11, 22). 
Cell Lines.  The human lymphoblastoid cell  lines Daudi, Victor, Seraphine, Raft, Wi-L2, 
RPMI  8866,  and Ramos Tubar 40379,  originally obtained from George Klein, Karolinska 
Institute Stockholm, Sweden, are well-established in culture and were grown in RPMI  1640 
supplemented with 10% fetal bovine serum (FBS). 
Nonlymphoid cells HeLa, Vero, and BSC- 1 were used, respectively, to compare measles virus 
replication with that in lymphoid cells, to grow the virus stocks, and to enumerate virus titers. 
These cell lines were cultured as previously described (22). Expression of measles virus antigen- 
infected cells was documented by immunofluorescence. The procedure and reagents used are 
defined (11, 22, 23). Electromicroscopy was also performed on such cells (11). 
Radioiodination.  The procedure of Phillips and Morrison was used with some modifications 
(24). At least 2 ×  107 lymphoblastoid or HeLa cells were washed twice with phosphate-buffered 
saline (PBS). After centrifugation at 250 g for 10 min, pellets were removed, resuspended in 250 
/~1 of PBS, and transferred to 1.5-ml Ependorfftubes. 1 U (10/~1) oflactoperoxidase (Calbiochem- 
Behring Corp., American Hoechst Corp., San Diego, Calif.) was added to the cells followed by 
1 mCi of 1~I (Amersham Corp., Arlington Heights, Ill.) The reaction was initiated by adding 
10/~1 of 0.03%  H202.  After 2 min, 10 more/~1  of 0.03% H202 was  added. The reaction was 
allowed to proceed for 2 more min and was stopped by dilution to 50 ml with PBS. Cells were 
washed once with minimum essential medium (MEM), and a  5-/~1 fraction was  counted to 
ensure that labeling was satisfactory. 
Cell-Cell  Fusion.  Uninfected, unlabeled Victor,  Raji,  or  Daudi  cells  washed  twice  with 
serum-free MEM were mixed with surface-labeled infected Daudi cells at a ratio of one infected 
Daudi cell to two uninfected cells. The cell mixtures were centrifuged at 250 g for 10 min, and 
the supernatant fluids were discarded. The pellets were gently resuspended in  1 ml of 50% 
polyethylene glycol  1,000 (J.  T.  Baker Chemical Co., Phillipsburg, N. J.)  and incubated at 
room temperature for  1 min.  1 ml of serum-free MEM was  added, followed  after  1 mR by 
another 2 ml of serum-free MEM. 2 min later, 4 ml of MEM supplemented with 20% FBS was 
added to stop the reaction. Counting with a  hemacytometer indicated that ~60-70% of the 
uninfected, unlabeled Victor, Daudi, or Raji cells were fused with the infected, labeled Daudi 
cells. 
Enzyme  Treatment.  The 2 ×  107 to 4  X  10  7 infected, labeled Daudi or HeLa cells used as 
controls were incubated with various dilutions  of TPCK-trypsin  or chymotrypsin (Worthington 
Biochemical Corp., Freehold, N. J.),  ranging from 0.01 to 500/~g/ml. Briefly,  infected cells 
were first radioiodinated as described above and then washed once with serum-free MEM and 
resuspended in 4 ml serum-free MEM containing  the selected enzyme. The cell-enzyme mixture 
was incubated for 15 rain at 37°C and then combined with 4 ml of MEM containing 20% FBS. 
The cells were washed twice with MEM-20% FBS and placed on ice. Finally, the enzyme- 
treated, labeled viral polypeptides were obtained by immunoprecipitation and analyzed by 
polyaerylamide gels (see below). 
To see  whether enzyme treatment of virus could  increase infectivity, supernatant fluids 
harvested from cultures of HeLa, Victor, or Daudi cells 24 h after infection were treated with 
enzyme in the following manner. Measles  virus containing supernates were diluted 1:2 with 
serum-free  MEM  containing the  appropriate  enzyme  (trypsin, chymotrypsin, or  pronase) 
(Caibiochem-Behring Corp.)  to final enzyme concentrations ranging from 0.1  to 500/~g/ml. ROBERT  S.  FUJINAMI AND MICHAEL B.  A. OLDSTONE 
TABLE  I 
Production of Infectious Measles  Virus by Lymphoblastoid Cell Lines* 
Cell line  PFU/ml 
HeLa  1.5 X 10  6 
Victor  2.5 ×  10  5 
Raji  2.5 x  10  5 
Ramos  2.0 ×  10  4 
Daudi  1.2 ×  l0  4 
* Cells were infected at an MOLl, and 24 h  later supernatant fluids were 
harvested.  The amount of measles virus present  in  fluids was assayed by 
plaquing on  BSC-1 monolayers and enumerated  as  PFU/ml supernatant 
fluid. 
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The virus-enzyme mixture was then incubated for  10 min at 37°C, after which serial tenfold 
dilutions were made  in  PBS  containing 5%  FBS. Infectivity was measured  immediately by 
plaque assay on BSC-1 cells and enumerated as PFU. 
Immunoprecipitation and Electrophoresis.  Enzyme treated, surface-labeled infected lymphoid or 
HeLa cell pellets were resuspended in 100 gl of human serum containing antibodies to measles 
virus polypeptides including both  HA and  F  proteins, as published  (22).  The  mixture was 
placed on ice. After 30 min, the cells were washed once with serum-free MEM and solubilized 
in 0.5 ml of 2% NP-40 containing 1 mM paramethylsulfonylfluoride in Tris sodium chloride 
EDTA buffer. This mixture was incubated on ice for 15 min with intermittent vortexing. After 
the nuclei and insoluble cell debris were pelleted by centrifugation at  1,000 g for 15 min, the 
supernatant fluids were removed and mixed with 125 gl of a  10% Staphylococcus aureus (Staph A) 
suspension to precipitate virus antigen-antibody complexes (22, 25, 26). The complexes bound 
to  the Staph  A  were washed  extensively, resuspended in sample preparation buffer with  or 
without  2-mercaptoethanol (ME)  (Eastman Kodak Co., Rochester, N. Y.), and immersed in 
boiling H20 for 2 rain. The mixture was then centrifuged at  1,000 g for 15 min to pellet the 
Staph A. The supernatant fluid was removed, and a fraction was counted for radioactivity, after 
which samples were loaded onto 10.5% sodium dodecyl sulfate polyacrylamide gels (22, 27). 
Plaque Assay,  Materials to be tested were plaqued on BSC-1  cell monolayers (22). 
Results 
Replication  of Measles  Virus in Lymphoblastoid  Cell Lines.  The seven lymphoblastoid 
cell  lines  infected  with  measles  virus  at  an  MOI  of  1  included  Daudi,  Victor, 
Seraphine,  Raji, Wi-L2, RPMI  8866,  and  Ramos  (2  ×  107 cells assayed). 24 h  after 
addition of virus, cells from the various lines were compared for their ability to express 
measles virus antigens. By immunofluorescence,  virtually 100%  of the cells from the 
seven different lines expressed large amounts of virus antigens on their surfaces. 
The  supernatant  fluids were collected from  these measles virus-infected cells and 
quantitated  for the amount  of infectious virus present.  Four representative lympho- 
blastoid cell lines are shown  in Table  I.  Infected Victor cells produced the highest 
titers of infectious virus and Daudi cells produced the lowest. Ramos cells most often 
produced amounts of infectious virus intermediate in titers. On a per cell basis, Victor 
cells produced at least ten times as much infectious virus as Daudi cells. These results 
were confirmed in repeated experiments. Victor, Seraphine, Raji, Wi-L2, and RPMI 
8866 produced equivalent amounts of infectious virus. 
Cell Surface  Virus Polypeptides.  To study measles virus antigens on  the surfaces of 
infected lymphoblastoid cells, 2 ×  107 cells were surface-labeled with 125I. The labeled 
viral polypeptides were  then  immunoprecipitated and  analyzed by sodium dodecyl 
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ing conditions. The various lymphoblastoid cells were compared to HeLa cells (Fig. 
1), whose surface polypeptides have recently been characterized (28). With HeLa cells 
under nonreducing conditions  (ME-), most of the HA migrated as a  dimer with  a 
160,000 mol wt, although occasionally some HA was also seen as an 80,000 mol wt 
monomer. The Fo protein migrated as a 64,000 mol wt polypeptide. Under reducing 
conditions  (ME+), the HA migrated as an 80,000 mol wt monomer, and F  protein 
now migrated at a 42,000 mol wt position (F1). With respect to all the lymphoblastoid 
lines studied, like HeLa cells, most if not all of the HA appeared in a  dimeric form 
that  converted  to  a  monomer  upon  reduction.  Similarly,  unreduced  Fo  protein 
migrated as a 64,000 mol wt polypeptide in most lymphoblastoid cell lines, i.e., Victor, 
Raji,  (shown in Fig.  1), Wi-L2, RPMI  8866, and Seraphine  (not shown), and upon 
reduction it converted to a 42,000 mol wt moiety. In contrast to these lymphoblastoid 
cell lines, in Ramos cells ~50% of the F protein appeared in the uncleaved form, and 
50% was in the cleaved form, as shown by ME treatment. In contrast to the other cell 
lines, the F protein from Daudi cells, under both reducing and nonreducing conditions, 
migrated only as a 64,000 mol wt polypeptide. Thus, the F protein was not cleaved or 
was  poorly cleaved on  Daudi  cells.  The  failure to  cleave F0  to  Fx  on  Daudi  cells 
paralled a  low production of infectious virus in repeated experiments. 
Cleavage of the F Protein.  To see whether the defect in Daudi cells could be overcome 
by fusion with other cell lines having the ability to cleave F  protein, the following 
experiment  was  conducted.  Infected,  surface-labeled  Daudi  cells  were  fused  with 
unifected Victor, Raji, or Daudi cells.  These viable fused cells were then mixed with 
anti-measles virus antibody to precipitate the surface viral polypeptides. After solu- 
bilization and Staph A treatment, the labeled antigens from these complexes (HA and 
F  originally on the infected Daudi  ceils) were identified by electrophoretic analysis 
and  quantitated  by removing individual  bands  and  determining  their radioactive 
counts.  By this  assay we determined that  well over one-half of the F  protein from 
labeled infected Daudi cells that  fused with uninfected Victor cells migrated at  the 
cleaved position, i.e.,  F1, 42,000 mol wt.  By comparison with  Daudi  cells plus Raji 
cells,  this  value was  slightly less  than  one-half, but  with  infected Daudi  cells plus 
FIG.  1.  Surface-labeled measles virus polypeptides. Viral antigens were labeled with 'zsI-, immu- 
noprecipitated, and analyzed electrophoretically. ME- samples electrophoresed in  the absence of 
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uninfected  Daudi cells, just  1/10  of the F0 input was cleaved (Table II). Therefore, 
Victor  and  Raji  cells that  ordinarily have  the  ability to  cleave  F  protein  enabled 
infected Daudi cells (deficient in this cleavage activity) to which  they were fused to 
now cleave the F protein. 
We  next  deterinined  whether  enzyme  treatment  of infected  Daudi  cells allowed 
cleavage of the F protein and enhanced production of infectious virus. Surface proteins 
expressed on viable infected Daudi cells were treated with trypsin (0.01  to 500 #g/ml, 
incubated at 37°C  for  15 min, and the cleavage of F0 to F1 was studied. As shown in 
Fig.  2,  minimal cleavage of the F  protein occurred  at 0.01  #g/ml,  but  all of the  F0 
protein  was  degraded  to  F1  after  treatment  with  1  #g/ml  of  trypsin.  When  a 
concentration of 10 #g/ml of trypsin was used, the HA was degraded. Chymotrypsin 
TABLE  II 
Cleavage ofF Protein after Cell-Cell Fusion * 
Fusion of 
Infected-125I  Uninfected 
Cleavage 
% 
DAUDI  DAUDI  10 
DAUDI  RAJI  40 
DAUDI  VICTOR  60 
* Viable, infected Daudi cells were radiolabeled with 1~I using the lactoper- 
oxidase method and then fused with uninfected Daudi, Raji, or Victor cells. 
Fusoma were incubated at 37°C for 2 h and thereafter conversion of F0 to Fl 
was analyzed using immunoprecipitation  and 10.5% sodium dodecyl sulfate 
gels. 
Fig.  2.  Autoradiogram of a25I surface-labeled measles virus polypeptides immunoprecipitated and 
analyzed electrophoretically.  Lane C depicts infected Daudi cells incubated without  trypsin. The 
next  lane represent  cells incubated with 0.01 pg trypsin/ml, and  other lanes represent  tenfold 
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had  no effect on cleavage of F0 to F1 because untreated and chymotrypsin-treated, 
surface labeled, infected Daudi cells reacted similarly over the same range of enzyme 
concentrations used  above.  However, with  10 #g/ml  or greater of chymotrypsin, a 
reduction of both the HA and F0 was observed. 
Production of Noninfectious  Virus.  Electron microscopy studies revealed that 24 h after 
infection with mealses virus, Daudi, Victor, and Raji ceils all contained nucleocapsid 
in their cytoplasms, and virus particles were budding from all of these cells' plasma 
membranes.  The amount  of virus budding  from Daudi  cells appeared  no different 
than the amount budding from Victor to Raji cells, yet the infectious virus made by 
Daudi cells was 1/10 that of Victor or Raji (Table I). This suggested that the defective 
production of infectious virus from Daudi cells might also be related to the inability 
to cleave F0 to F1. To test this possibility, we treated measles virus harvested from 
Daudi cells with trypsin. As shown in Table III, trypsin increased the infectivity of 
Daudi-grown virus by almost 2 logs compared with that of the untreated virus from 
these cells.  This  increased  titer caused  by trypsin  treatment  approximated  that  of 
HeLa- or Victor-grown virus. In contrast to its effect on Daudi cells, at none of these 
concentrations did trypsin increase the titer of measles virus grown in Victor or HeLa 
cells, although concentrations of >100 btg/ml decreased the infectivity of virus from 
any  of the  three  cell  lines.  Subjecting  Daudi-  or  HeLa-grown  measles  virus  to 
chrymotrypsin  (100 #g/ml  or  less)  neither  increased  nor  decreased  the  ordinarily 
observed titers of virus. Daudi-grown measles virus was shown to increase in infectivity 
by  ~50%  when  incubated  with  pronase  (50  /.tg/ml),  whereas  HeLa-grown  virus 
actually decreased by 50%. These experiments indicate that trypsin can cleave the F 
protein on cells or virions, rendering the F protein functional and, thus, fully capable 
of fusing with and infecting other cells.  In contrast, chymotrypsin lacked this ability. 
Lack of Temperature-sensitive  Mutants.  It was previously reported (29)  that lympho- 
blastoid  cell  lines  persistently  infected with  measles  virus  generated  temperature- 
sensitive mutants. To check for this possibility in our system, supernatant fluids from 
infected HeLa, Victor, and Daudi cells were plaqued on BSC-1 monolayers at 33°C 
or 39°C.  No difference in titers was  found between the cultures incubated at  33°C 
and those incubated at 39°C. 
Discussion 
We demonstrated that several human lymphoblastoid cell lines vary in their ability 
to produce infectious measles virus and that  the amount of infectious measles virus 
TABLE  III 
Increase of Measles Virus Infectivity by Trypsin Treatment* 
Enzyme 
Source of virus 
Daudi  HeLa 
Trypsin  3.5 X  10  4  9.2 X  10  a 
Chymotrypsin  4.0 X  10  2  1.1  X  10  4 
Pronase  3.6 X  10  2  4.0 ×  10  a 
None  7.5 ×  102  1.4 ×  104 
* Supernatant  fluids from  infected Daudi or HeLa cells were treated with 50 
#g trypsin, chymotrypsin, or pronase/ml for  10 rain at 37°C. Serial dilutions 
were made and these were assayed for infectivity on BSC- 1 monolayers. ROBERT S. FUJINAMI AND MICHAEL B. A. OLDSTONE  1495 
produced directly correlates with their ability to cleave the F  protein. Victor, Raji, 
Seraphine, Wi-L2, and RPMI 8866 lymphoid cells produce the most infectious virus 
and readily cleave F0 to F1. The quantities of infectious virus made and  F  protein 
cleaved were roughly equivalent  in  these various cell lines.  Ramos  lymphoid ceils 
made significantly less  virus than Victor, Raji,  Seraphine, Wi-L2, and RPMI 8866 
cells and cleaved quantitively one-half as much or less F0 to F1. Furthermore, Daudi 
cells  produced  the  lowest  titers  of virus  of any  lymphoid  cell  lines  studied  and 
correspondingly cleaved the least F protein. Thus, Daudi lymphoid cells are markedly 
defective and  Ramos lymphoid cells partially defective in their capacity to process 
the F protein, and this results in a  lower production of infectious virus. Cleavage of 
the F protein of other paramyxovirus leads to the acquisition of infectivity; the result 
is cell fusion and hemolysis due to conformational changes in the protein (30).  It has 
recently been suggested  (31,  32)  that  both Daudi  and  Ramos cells represent a  less 
differentiated lymphoid cell population than Raji, Wi-L2, or RPMI 8866. Daudi and 
Ramos cells that express IgM on their surfaces can be made to express IgG or IgD 
when given T  cell help or infected with Epstein Barr virus, respectively (31, 32). 
We next determined whether the inability of Daudi lymphoid cells to cleave F0 to 
F1 was due either to cells lacking appropriate enzyme(s) to cleave F protein or because 
Daudi cells contained the enzyme but also had an inhibitor that blocked its activity. 
By fusing surface-labeled, infected Daudi cells with uninfected Victor cells, we found 
that Victor cells could provide the needed enzyme(s) or functional capacity to cleave 
the F protein. Therefore, Daudi cells do not contain an inhibitor that interferes with 
processing of the F  protein but  are deficient in the enzyme(s)  to cleave F  protein. 
These results  also  suggest  that  the  cleavage event of F  protein can  occur in  close 
proximity to the infected cell's plasma membrane because the lactoperoxidase labeling 
technique used is restricted to tyrosine residues exposed at the cell's surface and does 
not  label  proteins  on  the  inner  surface  of a  plasma  membrane  (22,  28).  In  these 
experiments, fusion of membranes from two cells was required to cleave the F protein 
on the Daudi cell surface. Mixing the two cells types together without fusing was not 
sufficient to cleave the F protein. The results complement those of Silver et al.  (33), 
who demonstrated that  adsorption of noninfectious Sendal  virus to the surfaces of 
cells with the ability to cleave F  protein did not activate the virus and that the loss of 
proteolytie activity in  monkey kidney cells with  serial passage correlated with  the 
inability to make infectious Sendi virus. 
The deficiency of Daudi cells for an enzyme to cleave measles virus F protein did 
not interfere with the assembly or release of budding virus particles.  However, the 
particles produced were largely not infectious. Electron microscopic study of Daudi, 
Victor, and Raji lymphoid cells 24 h  after measles virus infection indicated that all 
these cells synthesized abundant quantities of nucleocapsids within the cytoplasm and 
had large amounts of budding virus on their plasma membrane. After being treated 
with the appropriate enzyme needed to cleave F0 to F1, supernatant fluids harvested 
from Daudi lymphoblastoid cells contained amounts of infectious virus equivalent to 
those shed by HeLa or Victor cells. These results, in concert with the lactoperoxidase 
labeling experiments, support the notion that cleavage of F protein can occur as a late 
event in the course of infection, occurring after F protein is synthesized and transported 
to the plasma membrane. Our data does not exclude the possibility that cleavage of 
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cell surface in a suitable cell (34). The small amount of infectious measles virus found 
in  association  with  infected Daudi  cells  suggests  that  Daudi  cells  do  not  have  an 
absolute  lack  of the  necessary cleavage enzyme for F  protein.  Alternatively, such 
cleavage of F protein may result from enzymes present in FBS (6). These two possible 
explanations are being studied in current experiments. 
We analyzed the specificity of enzymes that could cleave the F protein of measles 
virus using both biochemical and biological assays. Infected and  1~5I surface-labeled 
Daudi cells were treated with varying concentrations of trypsin. Amounts of_>0.1 #g 
cleaved the F protein, as shown by migration on polyacrylamide gel. Chymotrypsin 
did not cleave the F protein into a functional moiety over a wide concentration range 
(0.01-500/xg/ml), although at high concentrations both HA and F were lost from the 
cell  surface.  In  addition,  measles  virus  harvested  from  the  supernates  of infected 
Daudi  lymphoid  cells  was  also  treated  with  trypsin,  chymotrypsin,  or  pronase. 
Treatment with trypsin markedly enhanced virus infectivity (Table III). In contrast, 
chymotrypsin did not enhance infectivity titers at  a  low concentration  (0.1  /tg/ml) 
but decreased infectivity when used in a  higher concentration (500 pg/ml).  Pronase 
treatment increased the infectivity of measles virus harvested from Daudi lymphoid 
cells slightly but decreased infectivity of measles virus grown in HeLa cells.  Norrby 
and Gollmar (35) reported that trypsin treatment of measles virus produced particles 
deficient in hemagglutinin but having normal levels of F  protein. Others  (36)  have 
reported that paramyxovirus spread, giant cell, and syncytia formation are blocked 
with antibodies to F protein. These previous results together with our results support 
the conclusion that  cleavage of the F  protein is necessary for biological activity of 
measles virus. 
What are the biological implications of our findings? Measles virus acutely infects 
a  variety  of cells  in  vivo  during  natural  infection  but  persists  in  lymphoid  and 
neuronal  cells  (13-19).  Furthermore,  in  vitro  studies  show  that  measles  virus  can 
replicate in human  macrophages, B lymphocytes, T  lymphocytes and their subsets, 
and  persist  in  some  of these  cells  and  in  cultured  lymphoid  lines  (37-40).  An 
implication  of our  findings  is  that  measles  virus  infection  of specific  type(s)  of 
lymphoid cells or subpopulations may lead to persistence in the host in cells that lack 
or are deficient in the enzyme that cleaves F protein. Because many lymphocytes are 
long-lived cells and circulate throughout the body, such an infected lymphocyte with 
nonfunctional F protein on its surface would contain measles virus genome but persist 
many years after initial infection. Furthermore, the infected lymphocyte might traffic 
to distant sites and perhaps ultimately to an area of inflammation where proteolytic 
enzymes were locally present.  In  this  area, proteolytic enzymes might  cleave the F 
protein,  yielding  a  functional  molecule  on  the  plasma  membrane.  The  infected 
lymphocytes would then fuse with other susceptible cells in the local area, resulting in 
a  new  round  of virus  replication.  Finally,  resting  peripheral  blood  lymphocytes 
infected with measles virus do not express viral antigens even though the viral genome 
is present  within  the cell. These cells must  be stimulated with mitogens before the 
virus or antigens  are detected  (37-40).  Perhaps  during mitogen or antigen-specific 
activation of lymphocytes, enzymes needed for the production of mature virions are 
turned on. Once available, such enzymes could process viral F0 and F1, leading to a 
lytic infection with resultant release of infectious virus and subsequent death of the 
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Such a  mechanism might play a  role in the lack of appropriate immune response to 
tuberculin seen during measles virus infection (20), presumably because the antigenic- 
specific responder cell is deleted. 
Summary 
The  host-directed  cleavage of measles virus  fusion  protein  on infected  lymphoid 
cells was studied to understand  the mechanism of viral persistence in lymphoid cells 
in vivo. Several lymphoblastoid cell lines were infected with measles virus, and the 
viral glycoproteins expressed on the cell's surface were radiolabeled and analyzed for 
cleavage of fusion  (F0) to  F1  by sodium  dodecyl sulfate-polyacrylamide gel electro- 
phoresis.  Daudi  and  Ramos lymphoblastoid cells were  deficient  in  their  ability  to 
cleave  measles  virus  fusion  protein  and  correspondingly  produced  low  titers  of 
infectious  measles  virus,  Daudi  cells  being  more  defective  than  Ramos  cells.  In 
contrast,  other lymphoblastoid cells studied,  Victor,  Raji, Wi-L2,  RPMI 8866,  and 
Seraphine,  cleaved  the  fusion  polypeptide  and  made  significantly  more  infectious 
virus.  Despite their defect  in cleaving F  protein,  Daudi  cells were able to assemble 
and release (noninfectious) measles virus particles into the fluid phase. The deficit in 
Daudi cells was corrected by fusing infected Daudi cells with cleavage-competent cells 
such as Victor or Raji. Furthermore, the cleavage event performed by competent cells 
could be mimicked at  the plasma membrane by treating infected  Daudi  cells with 
trypsin,  implicating  the  role  of a  plasma  membrane  enzyme in  cleaving  F0  to  F1 
during measles virus infection.  Hence, lymphoid cells deficient  in the plasma mem- 
brane enzyme required to cleave F protein are permissive for measles virus, maintain 
viral gene products, produce mostly noninfectious virus, and fail to place the biologic 
activity Fx protein on their surfaces. 
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